Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venarus in Varicose Veins
NCT06367166Active, not recruiting
- Sponsor
- Ryazan State Medical University
- Start
- Apr 2023
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of micronized purified flavonoid fraction in Varicose Veins (5 arms), sponsored by Ryazan State Medical University. Primary endpoint: Changes in biochemical markers of venous wall remodeling at 6 months. Started Apr 2023; status: active, not recruiting.
02
Drugs
micronized purified flavonoid fraction
03
Conditions
Varicose Veins
Beyond the preview
Go deeper on NCT06367166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06367166.